Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ruzzi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|February 26, 2025
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic ApproachesLorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Cancers|February 11, 2023
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational ResearchLorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Frontiers in Psychiatry|December 27, 2021
Case Report: COVID-19 Infection With Gastrointestinal Symptoms and Mood Disorder: Criticalities in Differential Diagnosis, Therapy and Management of ComplicationsGiuseppina Borriello, Lisa Lavatelli, Francesca Ruzzi, et al.
Cells|February 9, 2024
IL-1 Family Members in Bone SarcomasLorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, et al.
Cancers|January 20, 2021
IFN-γ and CD38 in Hyperprogressive Cancer DevelopmentStefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, et al.
NPJ Vaccines|April 27, 2026
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibodyMaria Sofia Semprini, Chiara Cappello, Laura Scalambra, et al.
Biochimie|May 30, 2025
5.8S rRNA forms and ribosome heterogeneity in breast cancerGiulia Venturi, Federico Zacchini, Francesca Ruzzi, et al.
Methods in Cell Biology|November 8, 2024
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assayFrancesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
International Journal of Molecular Sciences|August 26, 2023
Virus-like Particle (VLP) Vaccines for Cancer ImmunotherapyFrancesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
Molecular Aspects of Medicine|December 4, 2024
Cancer vaccines: Target antigens, vaccine platforms and preclinical modelsFrancesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|February 26, 2025
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic ApproachesLorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Cancers|February 11, 2023
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational ResearchLorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Frontiers in Psychiatry|December 27, 2021
Case Report: COVID-19 Infection With Gastrointestinal Symptoms and Mood Disorder: Criticalities in Differential Diagnosis, Therapy and Management of ComplicationsGiuseppina Borriello, Lisa Lavatelli, Francesca Ruzzi, et al.
Cells|February 9, 2024
IL-1 Family Members in Bone SarcomasLorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, et al.
Cancers|January 20, 2021
IFN-γ and CD38 in Hyperprogressive Cancer DevelopmentStefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, et al.
NPJ Vaccines|April 27, 2026
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibodyMaria Sofia Semprini, Chiara Cappello, Laura Scalambra, et al.
Biochimie|May 30, 2025
5.8S rRNA forms and ribosome heterogeneity in breast cancerGiulia Venturi, Federico Zacchini, Francesca Ruzzi, et al.
Methods in Cell Biology|November 8, 2024
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assayFrancesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
International Journal of Molecular Sciences|August 26, 2023
Virus-like Particle (VLP) Vaccines for Cancer ImmunotherapyFrancesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
Molecular Aspects of Medicine|December 4, 2024
Cancer vaccines: Target antigens, vaccine platforms and preclinical modelsFrancesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Pageof 4